<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03734315</url>
  </required_header>
  <id_info>
    <org_study_id>OSTK-PMCF-DE-2018-01</org_study_id>
    <nct_id>NCT03734315</nct_id>
  </id_info>
  <brief_title>Routine Application of Ostenil® in Patients With Gonarthrosis</brief_title>
  <official_title>Routine Application of Ostenil® in Patients With Gonarthrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TRB Chemedica AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TRB Chemedica AG</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PMCF study to observe the routine application of Ostenil® in the treatment of pain and
      restricted mobility in degenerative and traumatic changes of the knee joint.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2019</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Pain Intensity compared to Baseline (VAS-slider)</measure>
    <time_frame>Day 7, Day 14, Day 21, Day 28, Day 84, Day 168, Day 252</time_frame>
    <description>Evaluation of Pain Intensity by the Patient on a 10 cm VAS-slider. 10 cm equals the worst pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Range of Motion compared to Baseline (Goniometer measurement)</measure>
    <time_frame>Day 7, Day 14, Day 21, Day 28, Day 84, Day 168</time_frame>
    <description>Assessment of the Range of Extension and Flexion of the Knee Joint using a Goniometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Subjective Therapy Evaluation (KOOS Questionnaire) compared to Baseline</measure>
    <time_frame>Day 84, Day 168</time_frame>
    <description>Knee injury and Osteoarthritis Outcome Score (KOOS) to assess Stiffness, Pain, Function (daily living) and Quality of Life on a 5-point Likert scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Subjective Symptom Evaluation (Overall Impression on a scale from 1 to 5)</measure>
    <time_frame>Day 7, Day 14, Day 21, Day 28, Day 84, Day 168, Day 252</time_frame>
    <description>The Change of Overall Subjective Symptom Evaluation on a scale from 1 (much improved) to 5 (much worse).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Treatment-Emergent Adverse Events</measure>
    <time_frame>Up to Day 252</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Gonarthrosis</condition>
  <arm_group>
    <arm_group_label>Ostenil®</arm_group_label>
    <description>3-5 injections of sodium hyaluronate 1 % (20 milligrams (mg) / 2.0 millilitres (ml)) in weekly interval.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ostenil®</intervention_name>
    <description>Ostenil® is a CE-certified viscoelastic solution for injection into the joint cavity, containing 1.0 % sodium hyaluronate from fermentation.</description>
    <arm_group_label>Ostenil®</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 with Gonarthrosis and a Recommendation for Treatment with Ostenil®.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects ≥ 18 years of age and in good general health condition

          -  Signed informed consent

          -  Existing Ostenil® recommendation for the treatment of gonarthrosis

        Exclusion Criteria:

          -  Known hypersensitivity to one of the Ostenil® components

          -  Presence of articular effusion in study-relevant knee joint

          -  Known pregnancy or lactating females

          -  Subjects not capable of contracting and of understanding the nature, risks,
             significance and implications of the clinical investigation and unable to form a
             rational intention in the light of these facts

          -  Subjects unable to understand informed consent or having a high probability of non
             compliance to the study procedures and / or non completion of the study according to
             investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Krüger-Franke, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MVZ am Nordbad</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raphaela Geiger</last_name>
    <phone>+49 89-461483-27</phone>
    <email>geiger@trbchemedica.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lucia Hopp</last_name>
    <phone>+49 89-461483-29</phone>
    <email>hopp@trbchemedica.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Orthopädisches Versorgungszentrum München-Ost</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81825</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Hoeltz, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orthopädie München</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>80331</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Zimmermann</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orthopädie am Altheimer Eck</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80331</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Rucker, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orthopädische Praxis am Isartor</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80331</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Gillesberger, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ am Nordbad</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80797</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Krüger-Franke, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orthopädische Praxis</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80993</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hermann Anetzberger, PD Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 30, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

